GC1111

Clinical trials for GC1111 explained in plain language.

Never miss a new study

Get alerted when new GC1111 trials appear

Sign up with your email to follow new studies for GC1111, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Extended hope: Year-Long study tests rare disease treatment

Disease control Completed

This study followed patients with Hunter syndrome for about one year to check the long-term safety and effectiveness of Hunterase enzyme replacement therapy. It included 30 patients who had already been receiving this treatment for at least six months. Researchers monitored walki…

Matched conditions: GC1111

Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control

Last updated Mar 09, 2026 14:24 UTC

GC1111

Get alerted when new GC1111 trials appear

Extended hope: Year-Long study tests rare disease treatment